The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family’s representation. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
PEPFAR cuts have been linked to a 45% decline in South African children receiving HIV treatment at US-supported healthcare sites. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
